36.06
전일 마감가:
$35.73
열려 있는:
$35.63
하루 거래량:
539.93K
Relative Volume:
0.56
시가총액:
$2.06B
수익:
$2.00B
순이익/손실:
$-119.19M
주가수익비율:
-16.47
EPS:
-2.19
순현금흐름:
$-61.88M
1주 성능:
+9.11%
1개월 성능:
+15.73%
6개월 성능:
-22.25%
1년 성능:
-30.92%
Enovis Corp Stock (ENOV) Company Profile
명칭
Enovis Corp
전화
(302) 252-9160
주소
2711 CENTERVILLE ROAD, WILMINGTON
ENOV을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ENOV
Enovis Corp
|
36.06 | 1.89B | 2.00B | -119.19M | -61.88M | -2.19 |
![]()
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-10-03 | 개시 | JMP Securities | Mkt Outperform |
2024-06-13 | 개시 | JP Morgan | Neutral |
2024-02-13 | 개시 | Stephens | Overweight |
2024-01-22 | 개시 | UBS | Buy |
2024-01-03 | 개시 | William Blair | Outperform |
2023-12-15 | 재확인 | Needham | Buy |
2023-10-20 | 개시 | ROTH MKM | Buy |
2023-06-26 | 개시 | Needham | Buy |
2023-05-12 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2022-10-12 | 개시 | Jefferies | Buy |
2022-10-11 | 개시 | Goldman | Buy |
2022-09-12 | 개시 | Canaccord Genuity | Buy |
2022-09-12 | 개시 | Evercore ISI | Outperform |
2022-06-28 | 개시 | Argus | Hold |
2022-06-27 | 재개 | Loop Capital | Buy |
2022-06-16 | 개시 | Wells Fargo | Equal Weight |
모두보기
Enovis Corp 주식(ENOV)의 최신 뉴스
Medical Devices & SuppliesSpecialty Stocks Q1 Highlights: Enovis (NYSE:ENOV) - Yahoo Finance
Canaccord cuts Enovis stock target to $70, maintains Buy rating By Investing.com - Investing.com South Africa
Canaccord cuts Enovis stock target to $70, maintains Buy rating - Investing.com Australia
Enovis (ENOV): Canaccord Genuity Lowers Price Target to $70 | EN - GuruFocus
Canaccord Adjusts Price Target for Enovis (ENOV) Following Q1 Re - GuruFocus
Enovis price target lowered to $70 from $75 at Canaccord - TipRanks
Enovis Corporation (NYSE:ENOV) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Conflicted on These Industrial Goods Names: Carrier Global (CARR), BrightView Holdings (BV) and Enovis (ENOV) - The Globe and Mail
Enovis Corporation’s Strong Q1 2025 Earnings Call - TipRanks
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
UBS Adjusts Price Target on Enovis to $65 From $75, Maintains Buy Rating - marketscreener.com
JMP Securities Cuts Enovis (NYSE:ENOV) Price Target to $55.00 - Defense World
Enovis Reports Strong Q1 2025 Results, Updates Financial Outlook - MSN
Analysts Offer Insights on Industrial Goods Companies: Enovis (ENOV), Boeing (BA) and Arlo Technologies (ARLO) - The Globe and Mail
Enovis’ first-quarter net sales grow 8% to USD 559 million - Medical Buyer
Enovis stock price target cut to $55 by JMP Securities - Investing.com South Africa
Where Enovis Stands With Analysts - Benzinga
JMP Securities Adjusts Target Price for Enovis (ENOV) | ENOV Sto - GuruFocus
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Sto - GuruFocus
Is Enovis (NYSE:ENOV) A Risky Investment? - simplywall.st
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Stock News - GuruFocus
Enovis (ENOV) Price Target Reduced by Citizens JMP Amid Positive Outlook | ENOV Stock News - GuruFocus
Enovis: Q1 Earnings Snapshot - New Haven Register
Enovis Q1 2025 slides: revenue beats expectations, profit guidance lowered on tariffs - Investing.com
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff Challenges - Yahoo Finance
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff Challenges By GuruFocus - Investing.com Canada
Enovis Corporation Reports Strong Q1 2025 Growth - TipRanks
Decoding Enovis Corp (ENOV): A Strategic SWOT Insight - GuruFocus
Transcript : Enovis Corporation, Q1 2025 Earnings Call, May 08, 2025 - marketscreener.com
Enovis CORP SEC 10-Q Report - TradingView
Enovis reports Q1 adjusted EPS 81c, consensus 74c - TipRanks
Earnings call transcript: Enovis Q1 2025 earnings beat expectations, stock drops - Investing.com Nigeria
Enovis: Strong Q1 2025 Performance and Strategic Growth Justify Buy Rating - TipRanks
Enovis Q1 2025 slides: revenue beats expectations, profit guidance lowered on tariffs By Investing.com - Investing.com South Africa
Enovis stock down on reduced earnings forecast, $20M tariff impact - MassDevice
Enovis Q1 Adjusted Earnings, Sales Rise; Updates 2025 Outlook - marketscreener.com
Enovis (ENOV) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Enovis Corp Q1 2025 Earnings: Revenue Surpasses Estimates at $55 - GuruFocus
Enovis Announces First Quarter 2025 Results | ENOV Stock News - GuruFocus
ENOV Surpasses Q1 Revenue Projections with Robust Performance | - GuruFocus
Enovis Corp Q1 2025 Earnings: Revenue Surpasses Estimates at $559M, EPS Misses with -$0.98 - GuruFocus
Enovis shares fall nearly 5% as Q1 revenue misses estimates, guidance disappoints - Investing.com Nigeria
Enovis earnings beat by $0.07, revenue fell short of estimates - Investing.com
Enovis Corporation Q1 2025 Financial Results - TradingView
Enovis Announces First Quarter 2025 Results - The Manila Times
Enovis (NYSE:ENOV) Posts Q1 Sales In Line With Estimates But Stock Drops - Yahoo Finance
Earnings Flash (ENOV) ENOVIS CORPORATION Reports Q1 Adjusted EPS $0.81, vs. FactSet Est of $0.74 - marketscreener.com
Enovis Corp (ENOV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):